Michael Cher
Michael Cher
Professor of Urology, Wayne State University
Verified email at
Cited by
Cited by
Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping
ML Cher, GS Bova, DH Moore, EJ Small, PR Carroll, SS Pin, JI Epstein, ...
Cancer research 56 (13), 3091-3102, 1996
Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy
The Journal of urology 160 (4), 1387-1391, 1998
CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: the role of bone microenvironment‐associated CXCL12
SR Chinni, S Sivalogan, Z Dong, JCT Filho, X Deng, RD Bonfil, ML Cher
The Prostate 66 (1), 32-48, 2006
Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone
JA Nemeth, JF Harb, U Barroso Jr, Z He, DJ Grignon, ML Cher
Cancer research 59 (8), 1987-1993, 1999
Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis
JA Nemeth, R Yousif, M Herzog, M Che, J Upadhyay, B Shekarriz, ...
Journal of the National Cancer Institute 94 (1), 17-25, 2002
Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer
ML Cher, D Macgrogan, R Bookstein, JA Brown, RB Jenkins, RH Jensen
Genes, Chromosomes and Cancer 11 (3), 153-162, 1994
Prostate cancer: the use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy
JS Wolf Jr, M Cher, M Dall'Era, JC Presti Jr, H Hricak, PR Carroll
The Journal of urology 153 (3), 993-999, 1995
Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM
D Kong, E Heath, W Chen, ML Cher, I Powell, L Heilbrun, Y Li, S Ali, ...
PloS one 7 (3), e33729, 2012
Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment
BF Sloane, S Yan, I Podgorski, BE Linebaugh, ML Cher, J Mai, ...
Seminars in cancer biology 15 (2), 149-157, 2005
Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis
ML Cher, HR Biliran Jr, S Bhagat, Y Meng, M Che, J Lockett, J Abrams, ...
Proceedings of the National Academy of Sciences 100 (13), 7847-7852, 2003
Lycopene and soy isoflavones in the treatment of prostate cancer
U Vaishampayan, M Hussain, M Banerjee, S Seren, FH Sarkar, J Fontana, ...
Nutrition and cancer 59 (1), 1-7, 2007
Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells
D Kong, Z Wang, SH Sarkar, Y Li, S Banerjee, A Saliganan, HRC Kim, ...
Stem Cells 26 (6), 1425-1435, 2008
Circulating tumor cells: finding the needle in the haystack
X Zhe, ML Cher, RD Bonfil
American journal of cancer research 1 (6), 740, 2011
Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1 …
M Toth, MM Bernardo, DC Gervasi, PD Soloway, Z Wang, HF Bigg, ...
Journal of Biological Chemistry 275 (52), 41415-41423, 2000
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
MK Conley-LaComb, A Saliganan, P Kandagatla, YQ Chen, ML Cher, ...
Molecular cancer 12 (1), 1-10, 2013
CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone
SR Chinni, H Yamamoto, Z Dong, A Sabbota, RD Bonfil, ML Cher
Molecular Cancer Research 6 (3), 446-457, 2008
Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer
EL Gheiler, MV Tefilli, R Tiguert, D Grignon, ML Cher, W Sakr, JE Pontes, ...
Urology 51 (5), 789-795, 1998
Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand …
Y Li, O Kucuk, M Hussain, J Abrams, ML Cher, FH Sarkar
Cancer research 66 (9), 4816-4825, 2006
Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue
Z Dong, RD Bonfil, S Chinni, X Deng, JC Trindade Filho, M Bernardo, ...
The American journal of pathology 166 (4), 1173-1186, 2005
Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein
Y Li, M Che, S Bhagat, KL Ellis, O Kucuk, DR Doerge, J Abrams, ML Cher, ...
Neoplasia 6 (4), 354-363, 2004
The system can't perform the operation now. Try again later.
Articles 1–20